Sterile Injectable Drugs Market Analysis, Share by Suppliers In Terms Of Value and Volume, and Forecast from 2019 – 2030

Sterile injectable drugs market is estimated to be over US$ 500.0 billion in 2019. It is anticipated to grow at a double-digit CAGR from 2019 to 2030.

The continual growth of the sterile injectable drugs market can be attributed to several factors that have led to the wide scale adoption of these drugs for treatment and speedy recovery. Moreover, growing demand for these drugs for treatment of chronic disease across the globe is anticipated to further contribute to the substantial growth during 2019 and 2030. To obtain better insights into the market scenario, prominent players are increasingly focusing on collaborative initiatives. In 2015, Pfizer acquired Hospira, a provider of infusion technologies, injectable drugs, and biosimilars. In 2018, Endo acquired Somerset Therapeutics, a developer and marketer of ophthalmic drug sterile injectable.

Major Key Players of the Sterile Injectable Drugs Market are:
Johnson & Johnson, Sanofi, Novo Nordisk A/S, Pfizer, AstraZeneca, Merck & Co., Johnson & Johnson Services, GlaxoSmithKline plc., Gilead Sciences, Inc. Baxter, and others.

Download PDF to Know the Impact of COVID-19 on “Sterile Injectable Drugs Market” at: https://www.marketindustryreports.com/pdf/165

The rising prevalence of chronic diseases has significantly promoted the need for new and more efficient drugs for treatment purposes. Moreover, rapid FDA approval of sterile injectable drugs and rising government funds for developments of healthcare sector are also propelling the growth of the global sterile injectable market growth.

Factors such as affordability, convenience, safety, and accurate dosage creates convenience for doctors and patients, which inturn has played a crucial role in driving the growth of the global sterile injectable market. Moreover, the drug is injected in the body via syringes and needles which is more effective when compared with oral medicines. This leads to a speedy recovery from diseases owing to which patients have to spend lesser time in hospitals. All these factors have been significant in contributing to the rising demand for sterile injectable drugs.

The Sterile Injectable Drugs Market is segmented on the basis of Molecule Type, Drug Class, Indication, Route of Administration and region.

Major Molecule Type of Sterile Injectable Drugs Market covered are:

• Small Molecule
• Large Molecule

Major Drug Class of Sterile Injectable Drugs Market covered are:

• Monoclonal Antibodies (mAbs)
• Immunoglobulin
• Vaccines
• Blood Factors
• Cytokines
• Peptide Hormones & Insulin

Major Indication of Sterile Injectable Drugs Market covered are:

• Neurology
• Oncology
• Cardiovascular Diseases
• Autoimmune Disorders
• Musculoskeletal Disorders
• Infectious Disorders & Cancer

Major Route of Administration of Sterile Injectable Drugs Market covered are:

• Subcutaneous (SC)
• Intravenous (IV) & Intramuscular (IM)

Research objectives:-

– To study and analyze the global Sterile Injectable Drugs consumption (value & volume) by key regions/countries, product type and application, history data.

– To understand the structure of the Sterile Injectable Drugs market by identifying its various sub-segments.

– Focuses on the key global Sterile Injectable Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competitive landscape, SWOT analysis, and development plans in the next few years.

– To analyze the Sterile Injectable Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.

– To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

Have any query? Inquiry about report at: https://www.marketindustryreports.com/inquiry/165

Table of Contents

1. INTRODUCTION
   1. Market Definition
   2. Market Classification
   3. Geographic Scope
   4. Years Considered for the Study: Historical Years – 2016 & 2017; Base Year – 2018; Forecast Years – 2019 to 2030
   5. Currency Used
2. RESEARCH METHODOLOGY
   1. Research Framework
   2. Data Collection Technique
   3. Data Sources
   4. Market Estimation Methodology
   5. Data Validation and Triangulation
3. ABSTRACT OF THE STUDY
4. MARKET DYNAMICS ASSESSMENT
   1. Overview
   2. Drivers
   3. Barriers/Challenges
   4. Opportunities
5. GLOBAL STERILE INJECTABLE DRUGS MARKET – ANALYSIS & FORECAST, BY MOLECULE TYPE
   1. Small Molecule
   2. Large Molecule
6. GLOBAL STERILE INJECTABLE DRUGS MARKET – ANALYSIS & FORECAST, BY DRUG CLASS 
   1. Monoclonal Antibodies (mAbs)
   2. Immunoglobulin
   3. Vaccines
   4. Blood Factors
   5. Cytokines
   6. Peptide Hormones
   7. Insulin
   8. Other Drug Classes
7. GLOBAL STERILE INJECTABLE DRUGS MARKET – ANALYSIS & FORECAST, BY INDICATION 
   1. Neurology
   2. Oncology
   3. Cardiovascular Diseases
   4. Autoimmune Disorders
   5. Musculoskeletal Disorders
   6. Infectious Disorders
   7. Cancer
   8. Other Indications
8. GLOBAL STERILE INJECTABLE DRUGS MARKET – ANALYSIS & FORECAST, BY ROUTE OF ADMINISTRATION
   1. Subcutaneous (SC)
   2. Intravenous (IV)
   3. Intramuscular (IM)
   4. Other Routes of Administration
9. GLOBAL STERILE INJECTABLE DRUGS MARKET – ANALYSIS & FORECAST, BY DISTRIBUTION CHANNEL
   1. Hospital Pharmacy
   2. Retail Pharmacy
   3. E-Commerce
10. GLOBAL STERILE INJECTABLE DRUGS MARKET – ANALYSIS & FORECAST, BY REGION
    1. North America Sterile Injectable Drugs Market
    2. Europe Sterile Injectable Drugs Market
    3. Asia Pacific Sterile Injectable Drugs Market
    4. Rest of the World (ROW) Sterile Injectable Drugs Market
11. COMPETITIVE LANDSCAPE
    1. Key Players & Their Competitive Positioning (2018)
    2. Key Strategies Assessment
       1. New Molecule Type Launches
       2. Merger & Acquisitions
       3. Agreements, Collaborations, & Partnerships
       4. Expansions
       5. Other Strategies
12. COMPANY PROFILES (Business Overview, Molecule Types Offered, Financial Performance, R&D Intensity, Marketing & Sales Intensity, Recent Developments, Analyst Corner)*
    1. Johnson & Johnson Services, Inc.
    2. Sanofi
    3. Novo Nordisk A/S
    4. Pfizer Inc.
    5. AstraZeneca
    6. Merck & Co., Inc.
    7. Johnson & Johnson Services, Inc.
    8. GlaxoSmithKline plc.
    9. Gilead Sciences, Inc.
    10. Baxter

*Financial details might not be captured in case of privately-held companies or for companies that do not report this information in public domain

Buy Exclusive Report @ https://www.marketindustryreports.com/checkout/165

About Us

Market Industry Reports is a global leader in market measurement and advisory services. It is 100% subsidiary of Maniks Systems Pvt Ltd. The firm has always been at the forefront of innovation to address the worldwide industry trends and opportunities.

We offer our clients a unique depth of market intelligence in an actionable format to move their business forward. Our analysis incorporates the consumer study in more than 100 countries that provide a tactical approach to drive the sustained growth for the business. We continue to pioneer state-of threat approach in research & analysis that makes complex world simpler to stay ahead of the curve. By nurturing the perception of genius and optimized market intelligence we bring proficient contingency to our clients in the evolving world of technologies, megatrends and industry convergence. We empower and inspire Vanguards to fuel and shape their business to build and grow world-class consumer products.

Contact Us-
Email: sales@marketindustryreports.com
Phone: + 91 8956767535
Website: https://www.marketindustryreports.com

Related Reports:

– Impact of COVID-19 on Sterile Injectable Drugs Market to Witness Growth Acceleration During 2019-2030 – Johnson & Johnson, Sanofi, Novo Nordisk